Connect with us

Government

Just In Time For The Taper: Treasury Cuts Long-Term Debt Sales For The First Time Since 2016

Just In Time For The Taper: Treasury Cuts Long-Term Debt Sales For The First Time Since 2016

Heading into today’s Treasury refunding announcement, consensus expected Janet Yellen to trim the size of the coming quarterly debt sale by roughly..

Published

on

Just In Time For The Taper: Treasury Cuts Long-Term Debt Sales For The First Time Since 2016

Heading into today's Treasury refunding announcement, consensus expected Janet Yellen to trim the size of the coming quarterly debt sale by roughly $2 billion per tenor, the first such cut in long-term debt sales since Feb 2016. And, with the Fed set to announce a taper later today, its joint-venture partner in Helicopter Money, the US Treasury did precisely as expected (and precisely as one would expect in a time of tapering), when it said it would sell $120 billion of long-term securities at auctions next week, down $6 billion from the record $126 billion level seen over the past three so-called quarterly refundings, as it plans to reduce coupon auction sizes across all maturities.

Specifically, the Treasury will sell:

  • $56BN of 3-year notes on Nov. 8, down from $58BN
  • $39BN of 10-year notes on Nov. 9, down from $41BN
  • $25BN of 30-year bonds on Nov. 10, down frrom $27BN.

The Treasury said the auctions will raise about $44.1BN in new cash.

Further cuts will be done in regular auctions of all longer-term securities in coming months, with the sole exception of inflation-linked debt. The deepest cutbacks will be in seven-year and 20-year Treasuries, which had seen bigger increases in issuance during the ramping up of debt sales to meet Covid-19 needs.

“Based on the latest fiscal outlook, current auction sizes are projected to provide excess borrowing capacity over the intermediate term,” Treasury says in statement. “Accordingly, Treasury intends to reduce auction sizes across all nominal coupon securities, starting with modest reductions over the upcoming November 2021 to January 2022 quarter. This approach reflects Treasury’s desire to preserve flexibility to adjust future financing plans in light of the remaining uncertainty in the fiscal outlook. Any additional issuance-size changes will be announced quarterly in subsequent refunding statements."

The Treasury added that it plans to address any seasonal or unexpected variations in borrowing needs - which will certainly come since the debt ceiling is still a thing - over the next quarter through changes in regular bill auction sizes and/or CMBs.

A summary of the Treasury's debt issuance schedule is shown below:

The table shows that over the following months, the Treasury will do the following:

  • Reduce sales of 2-, 3-year and 5-year note auctions by $2 billion per month over the next three months
  • Cut 7-year notes by $3 billion per month over the next three months
  • Decrease both the new and reopened 20-year bond auction sizes by $4 billion, starting in November
  • Reduce both the new and reopened 10-year note auction sizes by $2 billion, starting in November
  • Reduce both the new and reopened 30-year bond auction sizes by $2 billion, starting in November
  • Cut reopening sizes of floating rate note sales in November and December by $2 billion each, with the same reduction for the next new-issue two-year FRN in January

As for Treasury Inflation-Protected Securities, which compensate for increases in consumer prices, those will be kept steady over coming months. Dealers had predicted that TIPS wouldn’t be cut back. The follow are some details on the TIPS auction plans:

  • 10-year TIPS reopening in November of $14 billion
  • 5-year TIPS reopening in December of $17 billion
  • 10-year TIPS new issue in January of $16 billion

The Treasury said that the planned schedule through year-end will lead to TIPS auctions rising by a total of $17 billion in gross issuance for 2021 compared with 2020.

Overall, there were no surprises in today's announcement, which was in line with the expectations of Wall Street bond dealers who had predicted the Treasury would trim auctions of regular coupon bearing debt beginning this month. They did diverge on just how big the cuts would be for securities with 10 years or more to maturity.

November's $120BN refunding compares with $62BN as recently as November 2017; since then auction sizes across the curve rose to finance tax cuts in 2018 and then exploded in 2020 to fund the covid pandemic response.

The auction size reduction comes not only as the Fed begins to taper, but as Biden's fiscal stimulus plans have crashed and burned in Congress, shrinking in half from $3.5 trillion to $1.75 trillion and falling. This means that far less debt will be needed in the future and hence, smaller auctions.

“The slightly larger reductions in auctions sizes for the 7-year and 20-year coupon securities reflects Treasury’s desire to better balance structural supply and demand at those tenors,” which “were increased significantly more than others in response to the increased borrowing needs driven by the COVID-19 pandemic”

Curiously, on Monday, the Treasury increased its estimate of federal borrowing needs for the three months through December above $1 trillion as it scrambles to rebuild its cash pile ahead of the next debt ceiling deadline in early Dec.

US Treasury Sources and Uses table

Floating-rate note reopening size will drop by $2 billion for Nov and Dec (resulting in a $24 billion auction size for each).  Treasury anticipates decreasing the size of the next new-issue 2-year FRN auction in January by $2 billion to $26 billion. Changes in nominal and FRN auction sizes will reduce issuance to private investors by $84b compared to the previous quarter. Treasury Inflation-Protected Securities auctions during the quarter will include a $14b 10- year reopening in Nov., a $17b 5-year reopening in Dec. and a $16b 10-year new issue in Jan., the same size as in July

Regarding a SOFR-linked FRN, the department has decided it “is not necessary to meet its borrowing needs at this time.”

Addressing the debt limit, the Treasury said that Janet Yellen stated in a letter to Congress on October 18, 2021 that the $480 billion increase in the debt limit provided “a high degree of confidence that Treasury will continue to be able to finance the operations of the federal government through December 3, 2021.” The letter also stated that “it is imperative that Congress act  to increase or suspend the debt limit in a way that provides longer-term certainty that the government will satisfy all its obligations.”

Following the $480 billion debt limit increase signed into law on October 14, 2021, Treasury was able temporarily to increase its cash balance to a level closer to, albeit below, its stated cash balance policy, primarily through increases in regular benchmark bill auction sizes, as well as several large ad hoc CMBs. 

Amid the Treasury's scramble to rebuild its cash balance, the coupon-bearing auction trimming should give Treasury room to bolster bill supply, or rather once it’s no longer contrained by the limits of its borrowing authority when the debt ceiling situation is resolved. Even so, the Treasury anticipates that the supply of bills will generally decline from current levels until Congress acts again to increase or suspend the debt limit.  We saw precisely this yesterday when the Treasury also cut the size of future bill auctions. The Treasury also said it will continue to supplement its regular benchmark bill financing with weekly issuance of the 17-week CMB for Tuesday settlement, at least through the end of January.  Maintaining the 17-week CMB will provide the requisite flexibility to address potential changes in borrowing needs resulting from uncertainty associated with the fiscal outlook. 

Separately, after asking bond dealers ahead of Wednesday’s announcement about the idea of making the 17-week bill issuance routine, the Treasury said it’s not for now adding that as a benchmark.

The market reaction to the refunding announcement was modest, with the 20-year sector outperforming due to the outsized issuance cuts in the tenor, dropping the 10s20s30s butterfly spread to session lows after Treasury announces $4b cuts to 20-year bond refunding and reopening sales, the biggest of the reductions to auction sizes across the curve. The 10s20s30s fly richens from around 43bp before the announcement to under 40bp session lows in the aftermath. The 20s30s curve, which inverted last week for the first time, steepens back to near zero after the announcement.

Tyler Durden Wed, 11/03/2021 - 09:04

Read More

Continue Reading

Government

CDC Warns Thousands Of Children Sent To ER After Taking Common Sleep Aid

CDC Warns Thousands Of Children Sent To ER After Taking Common Sleep Aid

Authored by Jack Phillips via The Epoch Times (emphasis ours),

A…

Published

on

CDC Warns Thousands Of Children Sent To ER After Taking Common Sleep Aid

Authored by Jack Phillips via The Epoch Times (emphasis ours),

A U.S. Centers for Disease Control (CDC) paper released Thursday found that thousands of young children have been taken to the emergency room over the past several years after taking the very common sleep-aid supplement melatonin.

The Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia, on April 23, 2020. (Tami Chappell/AFP via Getty Images)

The agency said that melatonin, which can come in gummies that are meant for adults, was implicated in about 7 percent of all emergency room visits for young children and infants “for unsupervised medication ingestions,” adding that many incidents were linked to the ingestion of gummy formulations that were flavored. Those incidents occurred between the years 2019 and 2022.

Melatonin is a hormone produced by the human body to regulate its sleep cycle. Supplements, which are sold in a number of different formulas, are generally taken before falling asleep and are popular among people suffering from insomnia, jet lag, chronic pain, or other problems.

The supplement isn’t regulated by the U.S. Food and Drug Administration and does not require child-resistant packaging. However, a number of supplement companies include caps or lids that are difficult for children to open.

The CDC report said that a significant number of melatonin-ingestion cases among young children were due to the children opening bottles that had not been properly closed or were within their reach. Thursday’s report, the agency said, “highlights the importance of educating parents and other caregivers about keeping all medications and supplements (including gummies) out of children’s reach and sight,” including melatonin.

The approximately 11,000 emergency department visits for unsupervised melatonin ingestions by infants and young children during 2019–2022 highlight the importance of educating parents and other caregivers about keeping all medications and supplements (including gummies) out of children’s reach and sight.

The CDC notes that melatonin use among Americans has increased five-fold over the past 25 years or so. That has coincided with a 530 percent increase in poison center calls for melatonin exposures to children between 2012 and 2021, it said, as well as a 420 percent increase in emergency visits for unsupervised melatonin ingestion by young children or infants between 2009 and 2020.

Some health officials advise that children under the age of 3 should avoid taking melatonin unless a doctor says otherwise. Side effects include drowsiness, headaches, agitation, dizziness, and bed wetting.

Other symptoms of too much melatonin include nausea, diarrhea, joint pain, anxiety, and irritability. The supplement can also impact blood pressure.

However, there is no established threshold for a melatonin overdose, officials have said. Most adult melatonin supplements contain a maximum of 10 milligrams of melatonin per serving, and some contain less.

Many people can tolerate even relatively large doses of melatonin without significant harm, officials say. But there is no antidote for an overdose. In cases of a child accidentally ingesting melatonin, doctors often ask a reliable adult to monitor them at home.

Dr. Cora Collette Breuner, with the Seattle Children’s Hospital at the University of Washington, told CNN that parents should speak with a doctor before giving their children the supplement.

“I also tell families, this is not something your child should take forever. Nobody knows what the long-term effects of taking this is on your child’s growth and development,” she told the outlet. “Taking away blue-light-emitting smartphones, tablets, laptops, and television at least two hours before bed will keep melatonin production humming along, as will reading or listening to bedtime stories in a softly lit room, taking a warm bath, or doing light stretches.”

In 2022, researchers found that in 2021, U.S. poison control centers received more than 52,000 calls about children consuming worrisome amounts of the dietary supplement. That’s a six-fold increase from about a decade earlier. Most such calls are about young children who accidentally got into bottles of melatonin, some of which come in the form of gummies for kids, the report said.

Dr. Karima Lelak, an emergency physician at Children’s Hospital of Michigan and the lead author of the study published in 2022 by the CDC, found that in about 83 percent of those calls, the children did not show any symptoms.

However, other children had vomiting, altered breathing, or other symptoms. Over the 10 years studied, more than 4,000 children were hospitalized, five were put on machines to help them breathe, and two children under the age of two died. Most of the hospitalized children were teenagers, and many of those ingestions were thought to be suicide attempts.

Those researchers also suggested that COVID-19 lockdowns and virtual learning forced more children to be at home all day, meaning there were more opportunities for kids to access melatonin. Also, those restrictions may have caused sleep-disrupting stress and anxiety, leading more families to consider melatonin, they suggested.

The Associated Press contributed to this report.

Tyler Durden Mon, 03/11/2024 - 21:40

Read More

Continue Reading

International

Red Candle In The Wind

Red Candle In The Wind

By Benjamin PIcton of Rabobank

February non-farm payrolls superficially exceeded market expectations on Friday by…

Published

on

Red Candle In The Wind

By Benjamin PIcton of Rabobank

February non-farm payrolls superficially exceeded market expectations on Friday by printing at 275,000 against a consensus call of 200,000. We say superficially, because the downward revisions to prior months totalled 167,000 for December and January, taking the total change in employed persons well below the implied forecast, and helping the unemployment rate to pop two-ticks to 3.9%. The U6 underemployment rate also rose from 7.2% to 7.3%, while average hourly earnings growth fell to 0.2% m-o-m and average weekly hours worked languished at 34.3, equalling pre-pandemic lows.

Undeterred by the devil in the detail, the algos sprang into action once exchanges opened. Market darling NVIDIA hit a new intraday high of $974 before (presumably) the humans took over and sold the stock down more than 10% to close at $875.28. If our suspicions are correct that it was the AIs buying before the humans started selling (no doubt triggering trailing stops on the way down), the irony is not lost on us.

The 1-day chart for NVIDIA now makes for interesting viewing, because the red candle posted on Friday presents quite a strong bearish engulfing signal. Volume traded on the day was almost double the 15-day simple moving average, and similar price action is observable on the 1-day charts for both Intel and AMD. Regular readers will be aware that we have expressed incredulity in the past about the durability the AI thematic melt-up, so it will be interesting to see whether Friday’s sell off is just a profit-taking blip, or a genuine trend reversal.

AI equities aside, this week ought to be important for markets because the BTFP program expires today. That means that the Fed will no longer be loaning cash to the banking system in exchange for collateral pledged at-par. The KBW Regional Banking index has so far taken this in its stride and is trading 30% above the lows established during the mini banking crisis of this time last year, but the Fed’s liquidity facility was effectively an exercise in can-kicking that makes regional banks a sector of the market worth paying attention to in the weeks ahead. Even here in Sydney, regulators are warning of external risks posed to the banking sector from scheduled refinancing of commercial real estate loans following sharp falls in valuations.

Markets are sending signals in other sectors, too. Gold closed at a new record-high of $2178/oz on Friday after trading above $2200/oz briefly. Gold has been going ballistic since the Friday before last, posting gains even on days where 2-year Treasury yields have risen. Gold bugs are buying as real yields fall from the October highs and inflation breakevens creep higher. This is particularly interesting as gold ETFs have been recording net outflows; suggesting that price gains aren’t being driven by a retail pile-in. Are gold buyers now betting on a stagflationary outcome where the Fed cuts without inflation being anchored at the 2% target? The price action around the US CPI release tomorrow ought to be illuminating.

Leaving the day-to-day movements to one side, we are also seeing further signs of structural change at the macro level. The UK budget last week included a provision for the creation of a British ISA. That is, an Individual Savings Account that provides tax breaks to savers who invest their money in the stock of British companies. This follows moves last year to encourage pension funds to head up the risk curve by allocating 5% of their capital to unlisted investments.

As a Hail Mary option for a government cruising toward an electoral drubbing it’s a curious choice, but it’s worth highlighting as cash-strapped governments increasingly see private savings pools as a funding solution for their spending priorities.

Of course, the UK is not alone in making creeping moves towards financial repression. In contrast to announcements today of increased trade liberalisation, Australian Treasurer Jim Chalmers has in the recent past flagged his interest in tapping private pension savings to fund state spending priorities, including defence, public housing and renewable energy projects. Both the UK and Australia appear intent on finding ways to open up the lungs of their economies, but government wants more say in directing private capital flows for state goals.

So, how far is the blurring of the lines between free markets and state planning likely to go? Given the immense and varied budgetary (and security) pressures that governments are facing, could we see a re-up of WWII-era Victory bonds, where private investors are encouraged to do their patriotic duty by directly financing government at negative real rates?

That would really light a fire under the gold market.

Tyler Durden Mon, 03/11/2024 - 19:00

Read More

Continue Reading

Government

Fauci Deputy Warned Him Against Vaccine Mandates: Email

Fauci Deputy Warned Him Against Vaccine Mandates: Email

Authored by Zachary Stieber via The Epoch Times (emphasis ours),

Mandating COVID-19…

Published

on

Fauci Deputy Warned Him Against Vaccine Mandates: Email

Authored by Zachary Stieber via The Epoch Times (emphasis ours),

Mandating COVID-19 vaccination was a mistake due to ethical and other concerns, a top government doctor warned Dr. Anthony Fauci after Dr. Fauci promoted mass vaccination.

Coercing or forcing people to take a vaccine can have negative consequences from a biological, sociological, psychological, economical, and ethical standpoint and is not worth the cost even if the vaccine is 100% safe,” Dr. Matthew Memoli, director of the Laboratory of Infectious Diseases clinical studies unit at the U.S. National Institute of Allergy and Infectious Diseases (NIAID), told Dr. Fauci in an email.

“A more prudent approach that considers these issues would be to focus our efforts on those at high risk of severe disease and death, such as the elderly and obese, and do not push vaccination on the young and healthy any further.”

Dr. Anthony Fauci, ex-director of the National Institute of Allergy and Infectious Diseases (NIAID. in Washington on Jan. 8, 2024. (Madalina Vasiliu/The Epoch Times)

Employing that strategy would help prevent loss of public trust and political capital, Dr. Memoli said.

The email was sent on July 30, 2021, after Dr. Fauci, director of the NIAID, claimed that communities would be safer if more people received one of the COVID-19 vaccines and that mass vaccination would lead to the end of the COVID-19 pandemic.

“We’re on a really good track now to really crush this outbreak, and the more people we get vaccinated, the more assuredness that we’re going to have that we’re going to be able to do that,” Dr. Fauci said on CNN the month prior.

Dr. Memoli, who has studied influenza vaccination for years, disagreed, telling Dr. Fauci that research in the field has indicated yearly shots sometimes drive the evolution of influenza.

Vaccinating people who have not been infected with COVID-19, he said, could potentially impact the evolution of the virus that causes COVID-19 in unexpected ways.

“At best what we are doing with mandated mass vaccination does nothing and the variants emerge evading immunity anyway as they would have without the vaccine,” Dr. Memoli wrote. “At worst it drives evolution of the virus in a way that is different from nature and possibly detrimental, prolonging the pandemic or causing more morbidity and mortality than it should.”

The vaccination strategy was flawed because it relied on a single antigen, introducing immunity that only lasted for a certain period of time, Dr. Memoli said. When the immunity weakened, the virus was given an opportunity to evolve.

Some other experts, including virologist Geert Vanden Bossche, have offered similar views. Others in the scientific community, such as U.S. Centers for Disease Control and Prevention scientists, say vaccination prevents virus evolution, though the agency has acknowledged it doesn’t have records supporting its position.

Other Messages

Dr. Memoli sent the email to Dr. Fauci and two other top NIAID officials, Drs. Hugh Auchincloss and Clifford Lane. The message was first reported by the Wall Street Journal, though the publication did not publish the message. The Epoch Times obtained the email and 199 other pages of Dr. Memoli’s emails through a Freedom of Information Act request. There were no indications that Dr. Fauci ever responded to Dr. Memoli.

Later in 2021, the NIAID’s parent agency, the U.S. National Institutes of Health (NIH), and all other federal government agencies began requiring COVID-19 vaccination, under direction from President Joe Biden.

In other messages, Dr. Memoli said the mandates were unethical and that he was hopeful legal cases brought against the mandates would ultimately let people “make their own healthcare decisions.”

“I am certainly doing everything in my power to influence that,” he wrote on Nov. 2, 2021, to an unknown recipient. Dr. Memoli also disclosed that both he and his wife had applied for exemptions from the mandates imposed by the NIH and his wife’s employer. While her request had been granted, his had not as of yet, Dr. Memoli said. It’s not clear if it ever was.

According to Dr. Memoli, officials had not gone over the bioethics of the mandates. He wrote to the NIH’s Department of Bioethics, pointing out that the protection from the vaccines waned over time, that the shots can cause serious health issues such as myocarditis, or heart inflammation, and that vaccinated people were just as likely to spread COVID-19 as unvaccinated people.

He cited multiple studies in his emails, including one that found a resurgence of COVID-19 cases in a California health care system despite a high rate of vaccination and another that showed transmission rates were similar among the vaccinated and unvaccinated.

Dr. Memoli said he was “particularly interested in the bioethics of a mandate when the vaccine doesn’t have the ability to stop spread of the disease, which is the purpose of the mandate.”

The message led to Dr. Memoli speaking during an NIH event in December 2021, several weeks after he went public with his concerns about mandating vaccines.

“Vaccine mandates should be rare and considered only with a strong justification,” Dr. Memoli said in the debate. He suggested that the justification was not there for COVID-19 vaccines, given their fleeting effectiveness.

Julie Ledgerwood, another NIAID official who also spoke at the event, said that the vaccines were highly effective and that the side effects that had been detected were not significant. She did acknowledge that vaccinated people needed boosters after a period of time.

The NIH, and many other government agencies, removed their mandates in 2023 with the end of the COVID-19 public health emergency.

A request for comment from Dr. Fauci was not returned. Dr. Memoli told The Epoch Times in an email he was “happy to answer any questions you have” but that he needed clearance from the NIAID’s media office. That office then refused to give clearance.

Dr. Jay Bhattacharya, a professor of health policy at Stanford University, said that Dr. Memoli showed bravery when he warned Dr. Fauci against mandates.

“Those mandates have done more to demolish public trust in public health than any single action by public health officials in my professional career, including diminishing public trust in all vaccines.” Dr. Bhattacharya, a frequent critic of the U.S. response to COVID-19, told The Epoch Times via email. “It was risky for Dr. Memoli to speak publicly since he works at the NIH, and the culture of the NIH punishes those who cross powerful scientific bureaucrats like Dr. Fauci or his former boss, Dr. Francis Collins.”

Tyler Durden Mon, 03/11/2024 - 17:40

Read More

Continue Reading

Trending